About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials in Washington | 932 Studies

Clinical Trials Lung CancerWashington

Lung Cancer Clinical Trials in Washington

Find 932 clinical trials for lung cancer near Washington. Connect with research centers in your area.

All Lung Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 821-840 of 932 trials

Active not recruitingStudy of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast CancerTo evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer, or breast cancer measured by the…NCT03937154·Jonesboro, Arkansas and 138 others

Lung Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedTemsirolimus and Radiation for Non-Small Cell Lung CancerTo determine the maximum tolerated dose of the drug temsirolimus given with radiation therapy for patients with non-small cell lung cancer.NCT00796796·St Louis, Missouri

TerminatedADI-PEG 20 in Combination With Gemcitabine and Docetaxel After Progression on Frontline Therapy in Non-small Cell and Small Cell Lung CancersIn this study, patients with small cell or non-small cell lung cancer will receive ADI-PEG 20, gemcitabine, and docetaxel after demonstrated progression on frontline therapy.NCT05616624·Chicago, Illinois and 2 others

UnknownVaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerRATIONALE: Vaccines made from peptides may make the body build an effective immune response to kill tumor cells.NCT00104780·Ocoee, Florida and 8 others

CompletedA Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.To determine if the addition of AG-013736 to chemotherapy is beneficial in patients with advanced lung cancer who have not been previously treated.NCT00600821·Baton Rouge, Louisiana and 43 others

CompletedStudy Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former SmokersThe purpose of this study is to evaluate the safety and efficacy of veliparib plus carboplatin and paclitaxel versus the Investigator's choice of standard chemotherapy in adults…NCT02264990·Huntsville, Alabama and 139 others

RecruitingOsimertinib Alone or With Chemotherapy for EGFR-Mutant Lung CancersThis study will compare the effectiveness of osimertinib alone with the combination of osimertinib and chemotherapy (carboplatin and pemetrexed) in people with metastatic lung…NCT04410796·Sacramento, California and 17 others

CompletedA Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the BrainThe main purpose of this study is to evaluate the safety and effectiveness of the study drug known as abemaciclib in participants with hormone receptor positive breast cancer…NCT02308020·Duarte, California and 43 others

TerminatedA Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSideThe FORESEE Study is a multi-center, prospective clinical trial enrolling patients with Breast or Non-Small Cell Lung Cancer (NSCLC) who have suspicious or confirmed…NCT05414123·Stanford, California and 3 others

CompletedChemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung CancerThis study will compare the overall survival of participants with locally-advanced, Stage III Non-Small Cell Lung Cancer (NSCLC) with nonsquamous cell histology.NCT00686959·Birmingham, Alabama and 132 others

CompletedImatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerRATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00425646·Seattle, Washington

CompletedA Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung CancerThe objective of the proposed clinical trial is to investigate the safety and tolerability of CV301 in combination with Anti-PD1-Therapy in subjects with non-small cell lung…NCT02840994·Tampa, Florida and 6 others

TerminatedStudying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK)This is a Phase 1 trial evaluating the safety and efficacy of crizotinib in patients with tumors except non-small cell lung cancer that are positive for ALK.NCT01121588·Fayetteville, Arkansas and 20 others

UnknownDocetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung CancerRATIONALE: Drugs used in chemotherapy such as docetaxel use different ways to stop tumor cells from dividing so they stop growing or die.NCT00030641·Birmingham, Alabama and 43 others

CompletedS1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)This randomized clinical trial studies prophylactic colony stimulating factor management in patients with breast, colorectal or non-small cell lung cancer receiving chemotherapy…NCT02728596·Jonesboro, Arkansas and 159 others

TerminatedStudy of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other Solid Tumors With NRG1/ERBB Gene FusionsOpen-label, Phase 2, single treatment arm, 3 cohortsNCT03805841·Irvine, California and 13 others

Active not recruitingMAGE-A4ᶜ¹º³²T for Multi-TumorThis study will investigate the safety and tolerability of MAGE-A4ᶜ¹º³²T cell therapy in subjects who have the appropriate HLA-A2 tissue marker and whose urinary bladder…NCT03132922·Miami, Florida and 10 others

CompletedARCHER 1009 : A Study Of Dacomitinib (PF-00299804) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung CancerThis is a multinational, multicenter, randomized,double-blinded, Phase 3 study comparing the efficacy and safety of treatment with PF-00299804 to treatment with erlotinib in…NCT01360554·Birmingham, Alabama and 223 others

CompletedStudy Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566To assess the safety and tolerability at increasing dose levels of PF-04518600 alone or in combination wtih PF-05082566 in patients with select advanced or metastatic carcinoma in…NCT02315066·Los Angeles, California and 29 others

CompletedSubcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung CancerThe primary objective of this study is to assess the activity of subcutaneous (SC) amifostine on the incidence and severity of acute radiochemotherapy-induced esophagitis in…NCT00081315·Los Angeles, California and 23 others

PreviousPage 42 of 47Next

Other Conditions in Washington

Breast Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma